Skip to content

Topical Formulation CRO Services

From enhancing skin appearance to therapeutic breakthroughs.

Adopting a tailored approach to topical research based on the characteristics of the product and its intended use, ethica CRO delivers cost-effective solutions for cosmeceuticals to generate preliminary, exploratory, and importantly, publishable data. Our strategies support clients from the initial stages of research to the commercialization of potential therapeutic advancements.

Cosmeceutical and Therapeutic Topicals Experience

ethica leverages dermatological techniques and insights, enhancing beauty and addressing medical skin conditions.

Expertise in Regulatory Navigation

Our team expertly navigates regulations, launching cosmeceuticals to an FDA approval pathway.

Data-Driven Product Development

Our data-driven approach optimizes the cosmeceutical transition to therapeutic drugs, maximizing ROI with efficient solutions.

Discover how our clinical expertise can benefit your clinical trials for cosmeceuticals and topical formulations.

The expertise of our dermatology CRO in cosmeceuticals, prescription drugs, and natural products drives research in dermatological innovations like topical retinoids and moisturizers, all validated through rigorous research.

Are you integrating exosomes for regenerative aesthetics, or enhancing collagen production for anti-aging benefits? Through comprehensive clinical trials and ethical oversight, we can help guide your products from cosmetic breakthroughs to FDA approvals. Trust us to deliver scientific excellence and precision in securing your product’s success.

Explore the intersection of cosmeceuticals and therapeutic effectiveness

At ethica CRO, we utilize rigorous scientific methods to transform cosmeceuticals into therapeutic alternatives, offering a tailored, adaptable approach for each unique product. Our expertise allows for efficient commercialization, blending rigorous study design with flexible implementation of marketing objectives. Specializing in dermatological research, we guide clients through the complexities of regulatory approval, maximizing revenue by leveraging robust data to explore potential therapeutic paths with less risk and cost, and ensuring outcome measures are expertly managed.

Advantages of dermatology-tested products

Ensuring formulations are dermatology-tested not only guarantees scientific validation, enhancing safety and reliability for consumers but also bolsters dermatologists’ confidence in recommending these products to their patients. This methodology elevates product trustworthiness, fostering trust in its efficacy and safety across both professional and consumer audiences.

Our proportionate approach to risk and data

Understanding the significance of adopting a proportionate approach, ethica CRO tailors services to your product’s risk and required data sophistication. Our adaptability and commitment to excellence in navigating product development complexities optimizes resource use and the utility of project outcomes.

Maximizing value from your research

Within the cosmeceutical sector, select products hold the promise of evolving into therapeutic options. Utilizing stringent scientific methodologies, our goal is to uncover and enhance these properties, transforming cosmeceutical into treatments that offer substantial benefits to patients. Our experienced team can provide you with strategic insight to achieve both scientific and commercial success.

Leverage ethica’s experience in therapeutic dermatology research

ethica is the CRO of choice for biotech, cosmeceuticals and exosome-based topical research. Our extensive experience managing research programs with topical therapeutic products uniquely equips us to lead groundbreaking advancements in wound healing, skin rejuvenation, and anti-aging solutions.

Case Study: Pioneering Eczema Treatment through Natural Small Molecule Candidates

A biotech firm, focusing on natural small molecule research for dermatological applications, encountered a challenge in choosing a lead candidate for a topical eczema treatment. In search of expertise, the company formed a strategic partnership with ethica CRO, renowned for its proficiency in dermatology. ethica CRO suggested an innovative path forward: exploratory cosmeceutical research specifically for topical applications. This method efficiently identified a promising topical molecule, propelling the project into the pre-IND phase.

Leveraging the insights gained from the exploratory research, ethica CRO, in collaboration with the biotechnology firm, is actively progressing through the planning and initiation of a Phase II clinical trial. This strategic approach aims to validate the molecule’s efficacy in alleviating eczema symptoms, setting the stage for securing further venture capital investment under favorable terms and enabling a detailed risk analysis for potential IND application.

The anticipated approval signifies a transformative step in the journey of the topical cosmeceutical, positioning it as a potential therapeutic solution for eczema. Motivated by this progress, the biotech firm is keen to explore its portfolio for more natural molecules that could serve as innovative topical dermatological therapies.

This collaborative effort highlights the dynamic interplay between biotechnological innovation and strategic clinical research execution. ethica CRO is instrumental in guiding the topical molecule from its conceptual phase toward market readiness, emphasizing an innovation-led, participant-focused methodology in the development of novel dermatological treatments.